Alpco assay
ADMA (Mouse/Rat) ELISA
ALPCO Catalog Number: 30-3001
| ADMA (Mouse/Rat) ELISA | ||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO-synthase. It is
formed during proteolysis of methylated proteins and removed by renal excretion or
metabolic degradation by the enzyme dimethylarginine dimethylaminohydrolase
(DDAH). Several cell types, including human endothelial and tubular cells, are capable
of synthesizing and metabolizing ADMA. Elevated ADMA concentrations in the blood
are found in numerous diseases associated with endothelial dysfunction. For example, elevated ADMA levels in the blood of individuals on dialysis correlate significantly with the degree of arteriosclerosis and cardiovascular risk. Furthermore, elevated ADMA levels are found in individuals with hypercholesterolemia, hypertension, arteriosclerosis, chronic renal failure, and chronic heart failure, and are associated with restrictions in endothelial vasodilatation.
Tags
NO, nitric oxide, ADMA, asymmetric dimethylarginine, asymetric, di-methylarginine
For Research Use Only
Format:
Download Protocol

